ulcerative colitis (UC)

In this online exclusive, David Fraser, product manager Lateral Flow Services at BBI Solutions, discusses how easily-accessible diagnostic options could help lessen the burden on global health services. Read more


A label change for MSD’s (known as Merck in the US and Canada) ulcerative colitis (UC) treatment — SIMPONI (golimumab) — has received approval from the European Commission. Read more